Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Mark L. Day"'
Autor:
Zeqi Niu, Molly Kozminsky, Kathleen C. Day, Luke J. Broses, Marian L. Henderson, Christopher Patsalis, Rebecca Tagett, Zhaoping Qin, Sarah Blumberg, Zachery R. Reichert, Sofia D. Merajver, Aaron M. Udager, Phillip L. Palmbos, Sunitha Nagrath, Mark L. Day
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 57, Iss , Pp 101036- (2024)
Assessing the molecular profiles of bladder cancer (BC) from patients with locally advanced or metastatic disease provides valuable insights, such as identification of invasive markers, to guide personalized treatment. Currently, most molecular profi
Externí odkaz:
https://doaj.org/article/2bf02dafe4674b49bd058a098275693d
Autor:
Xiaotian Tan, Kathleen C. Day, Xuzhou Li, Luke J. Broses, Wen Xue, Weishu Wu, William Y. Wang, Ting-Wen Lo, Emma Purcell, Sicong Wang, Yun-Lu Sun, Maung Kyaw Khaing Oo, Brendon M. Baker, Sunitha Nagrath, Mark L. Day, Xudong Fan
Publikováno v:
Biosensors and Bioelectronics: X, Vol 8, Iss , Pp 100066- (2021)
The functional membrane proteins on tumor-cell-derived EVs contain a large amount of biomolecular information, and can serve as a comprehensive marker to delineate the molecular nature of cancer. However, due to low secretion rates, it is difficult t
Externí odkaz:
https://doaj.org/article/f0e5c940854b43aa825d015c3ef79244
Autor:
Petros D. Grivas, Kathleen C. Day, Andreas Karatsinides, Alyssa Paul, Nazia Shakir, Iya Owainati, Monica Liebert, Lakshmi P. Kunju, Dafydd Thomas, Maha Hussain, Mark L. Day
Publikováno v:
Molecular Medicine, Vol 19, Iss 1, Pp 367-376 (2013)
Abstract Members of the human epidermal growth factor receptor (HER) family play a significant role in bladder cancer progression and may underlie the development of chemotherapy resistance. Dacomitinib is an irreversible tyrosine kinase inhibitor wi
Externí odkaz:
https://doaj.org/article/4bd9bc2842c24f6aa6e35dc56a38a58c
Autor:
Rainer Kuefer, Kathleen C. Day, Celina G. Kleer, Michael S. Sabel, Matthias D. Hofert, Sooryanarayana Varambally, Christoph S. Zorn, Arul M. Chinnaiyan, Mark A. Rubin, Mark L. Day
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 8, Iss 4, Pp 319-329 (2006)
The aim of the current study was to evaluate the expression of ADAM15 disintegrin (ADAM15) in a broad spectrum of human tumors. The transcript for ADAM15 was found to be highly upregulated in a variety of tumor cDNA expression arrays. ADAM15 protein
Externí odkaz:
https://doaj.org/article/b6d8dda9f5df4855abfe34828ef6073a
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 7, Iss 2, Pp 141-151 (2005)
The retinoblastoma tumor suppressor (pRb) has traditionally been studied as a negative regulator of cell cycle progression through its interactions with the E2F family of transcription factors. Utilizing prostate epithelial cell lines established fro
Externí odkaz:
https://doaj.org/article/8209d0dd7fed4a69bf4a317798715d0b
Autor:
Mark L. Day, Todd Morgan, Sunitha Nagrath, Dafydd Thomas, Evan Keller, Kathleen Woods Ignatoski, Andrew Chou, Steven James Wilson, Layla El-Sawy, Stephanie Daignault-Newton, Nallasivam Palanisamy, Christopher Hall, Lakshmi P. Kunja, Rajal Shah, Luke J. Broses, Alyssa Paul, Scott J. Dawsey, Molly Kozminsky, Guadalupe Lorenzatti Hiles, Kathleen C. Day
Tibia xenograft histology of lapatinib, and cetuximab+trastuzumab treated animals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f17086a260777c1dbc7d2eb883daff
https://doi.org/10.1158/0008-5472.22412687.v1
https://doi.org/10.1158/0008-5472.22412687.v1
Autor:
Mark L. Day, Todd Morgan, Sunitha Nagrath, Dafydd Thomas, Evan Keller, Kathleen Woods Ignatoski, Andrew Chou, Steven James Wilson, Layla El-Sawy, Stephanie Daignault-Newton, Nallasivam Palanisamy, Christopher Hall, Lakshmi P. Kunja, Rajal Shah, Luke J. Broses, Alyssa Paul, Scott J. Dawsey, Molly Kozminsky, Guadalupe Lorenzatti Hiles, Kathleen C. Day
Activation of the EGF receptors EGFR (ErbB1) and HER2 (ErbB2) drives the progression of multiple cancer types through complex mechanisms that are still not fully understood. In this study, we report that HER2 expression is elevated in bone metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::252c06a1d7c613203c43d53414d48cb3
https://doi.org/10.1158/0008-5472.c.6508493.v1
https://doi.org/10.1158/0008-5472.c.6508493.v1
Autor:
Mark L. Day, Todd Morgan, Sunitha Nagrath, Dafydd Thomas, Evan Keller, Kathleen Woods Ignatoski, Andrew Chou, Steven James Wilson, Layla El-Sawy, Stephanie Daignault-Newton, Nallasivam Palanisamy, Christopher Hall, Lakshmi P. Kunja, Rajal Shah, Luke J. Broses, Alyssa Paul, Scott J. Dawsey, Molly Kozminsky, Guadalupe Lorenzatti Hiles, Kathleen C. Day
Supplemental materials, methods and figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91727b11d0041411d6795ebd05905e72
https://doi.org/10.1158/0008-5472.22412702
https://doi.org/10.1158/0008-5472.22412702
Autor:
Max S. Wicha, Hasan Korkaya, Daniel F. Hayes, Dafydd G. Thomas, Celina G. Kleer, Mark L. Day, Whitney A. Chadwick, Shawn G. Clouthier, Tahra K. Luther, Nader Tawakkol, Amber N. Heath, Nallasivam Palanisamy, Christopher L. Hall, April Davis, Stephanie Daignault, Kathleen Woods Ignatoski, Ahmed A. Quraishi, Tom F. Bersano-Begey, Scott J. Dawsey, Qin Zen, Fayaz Malik, Kathleen C. Day, Suthinee Ithimakin
PDF file - 491K, Supplementary Figure 3. Effect of trastazumab on stem cell marker expression. Supplementary Figure 2. Trastuzumab inhibits tertiary tumorsphere formation in luminal cell lines. Supplementary Figure 1. Representative FACS analysis dem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::560abdc1fd7d537096d1f2568089c598
https://doi.org/10.1158/0008-5472.22400423.v1
https://doi.org/10.1158/0008-5472.22400423.v1
Autor:
Mark L. Day, Kirk J. Wojno, Michael J. Imperiale, Stephanie Daignault, Jonathan A. Low, Michael T. McCabe
Supplementary Table 1 from Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed00166cd414fa12e5cd05cba3aa39f
https://doi.org/10.1158/0008-5472.22365240
https://doi.org/10.1158/0008-5472.22365240